MAZE THERAPEUTICS INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$31.48
-1.41%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
+18.1%
3 months
+15.2%
6 months
+15.9%
1 year
-5.2%
Year to date
-24.0%
52-week range
$22.39 – $51.84
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$1.75B
P/E
-13.1
P/B
3.9
P/S
87.4
Revenue
$20M
Net income
-$133.59M
Diluted EPS
-2.47
Gross margin
100.00%
Net margin
-667.90%
Return on equity
-34.90%
Total debt
$60.42M
Cash
$203.73M
Free cash flow
-$106.84M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $0 | -$44.73M | — | — | -$15.16M |
| Mar 31, 2026 | $20M | -$24.21M | 100.00% | -121.00% | -$39.21M |
| Dec 31, 2025 | $0 | -$34.57M | — | — | -$27.76M |
| Sep 30, 2025 | $0 | -$30.09M | — | — | -$24.71M |
| Jun 30, 2025 | $0 | -$33.68M | — | — | -$30.45M |
| Mar 31, 2025 | $0 | -$32.79M | — | — | -$29.82M |
| Dec 31, 2024 | $0 | -$29.58M | — | — | -$23.06M |
| Sep 30, 2024 | — | — | — | — | — |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent MAZE news
All market newsNo ticker-linked stories are in the current archive.